Document Detail


A family history of type 2 diabetes increases risk factors associated with overfeeding.
MedLine Citation:
PMID:  20461357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS/HYPOTHESIS: The purpose of the study was to test prospectively whether healthy individuals with a family history of type 2 diabetes are more susceptible to adverse metabolic effects during experimental overfeeding. METHODS: We studied the effects of 3 and 28 days of overfeeding by 5,200 kJ/day in 41 sedentary individuals with and without a family history of type 2 diabetes (FH+ and FH- respectively). Measures included body weight, fat distribution (computed tomography) and insulin sensitivity (hyperinsulinaemic-euglycaemic clamp). RESULTS: Body weight was increased compared with baseline at 3 and 28 days in both groups (p < 0.001), FH+ individuals having gained significantly more weight than FH- individuals at 28 days (3.4 +/- 1.6 vs 2.2 +/- 1.4 kg, p < 0.05). Fasting serum insulin and C-peptide were increased at 3 and 28 days compared with baseline in both groups, with greater increases in FH+ than in FH- for insulin at +3 and +28 days (p < 0.01) and C-peptide at +28 days (p < 0.05). Fasting glucose also increased at both time points, but without a significant group effect (p = 0.1). Peripheral insulin sensitivity decreased in the whole cohort at +28 days (54.8 +/- 17.7 to 50.3 +/- 15.6 micromol min(-1) [kg fat-free mass](-1), p = 0.03), and insulin sensitivity by HOMA-IR decreased at both time points (p < 0.001) and to a greater extent in FH+ than in FH- (p = 0.008). Liver fat, subcutaneous and visceral fat increased similarly in the two groups (p < 0.001). CONCLUSIONS: Overfeeding induced weight and fat gain, insulin resistance and hepatic fat deposition in healthy individuals. However, individuals with a family history of type 2 diabetes gained more weight and greater insulin resistance by HOMA-IR. The results of this study suggest that healthy individuals with a family history of type 2 diabetes are predisposed to adverse effects of overfeeding. TRIAL REGISTRATION: ClinicalTrials.gov NCT00562393 FUNDING: The study was funded by the National Health and Medical Research Council (NHMRC), Australia (no. #427639).
Authors:
D Samocha-Bonet; L V Campbell; A Viardot; J Freund; C S Tam; J R Greenfield; L K Heilbronn
Related Documents :
18666027 - Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical dis...
16311087 - Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transa...
16759927 - Effects of transdermal testosterone administration on insulin sensitivity, fat mass and...
8338037 - Relationship of dietary saturated fatty acids and body habitus to serum insulin concent...
8288047 - Skeletal muscle vascular transport capacity in diabetic rats.
19580357 - The prescription of insulin pen devices versus syringes for older people with diabetes.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-12
Journal Detail:
Title:  Diabetologia     Volume:  53     ISSN:  1432-0428     ISO Abbreviation:  Diabetologia     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-06-25     Completed Date:  2010-09-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1700-8     Citation Subset:  IM    
Affiliation:
Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00562393
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Analysis of Variance
Australia
Body Composition
C-Peptide / blood
Diabetes Mellitus, Type 2 / blood,  physiopathology*
Feeding Behavior / physiology*
Female
Genetic Predisposition to Disease
Glucose / metabolism
Humans
Insulin / blood
Insulin Resistance
Leptin / blood
Male
Middle Aged
Overnutrition / blood,  physiopathology*
Risk Factors
Sedentary Lifestyle
Weight Gain / physiology*
Chemical
Reg. No./Substance:
0/C-Peptide; 0/Leptin; 11061-68-0/Insulin; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mou...
Next Document:  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in hu...